v3.21.2
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Sep. 30, 2021
Dec. 31, 2020
Current assets    
Cash and cash equivalents $ 340,565 $ 228,713
Marketable securities, at fair value 202,144 67,546
Accounts receivable, net 104,964 106,843
Inventories 21,834 29,526
Prepaid assets 14,618 11,547
Assets held for sale 10,050 0
Other current assets 15,755 4,555
Total current assets 709,930 448,730
Property and equipment (net of accumulated depreciation of $112,185 and $92,895, respectively) 107,172 85,873
Operating lease right-of-use assets 102,310 45,786
Intangible assets, net 450,802 120,653
Goodwill 525,802 211,083
Restricted cash 3,161 21,919
Investment in non-consolidated affiliate 0 29,555
Prepaid lease asset 0 20,229
Other assets 7,210 4,503
Total non-current assets 1,196,457 539,601
Total assets 1,906,387 988,331
Current liabilities    
Accounts payable 28,536 24,965
Accrued compensation 32,283 24,727
Accrued expenses and other liabilities 18,088 11,654
Current portion of equipment financing obligations 1,564 2,841
Current portion of operating lease liabilities 6,988 4,967
Pharma contract liabilities 5,278 4,029
Total current liabilities 92,737 73,183
Long-term liabilities    
Convertible senior notes, net 531,779 168,120
Equipment financing obligations 152 967
Operating lease liabilities 72,336 42,296
Deferred income tax liabilities, net 57,706 5,415
Other long-term liabilities 14,432 4,056
Total long-term liabilities 676,405 220,854
Total liabilities 769,142 294,037
Commitments and contingencies (Note 14)
Stockholders’ equity    
Common stock, $0.001 par value, (250,000,000 shares authorized; 123,217,010 and 112,075,474 shares issued and outstanding, respectively) 123 112
Additional paid-in capital 1,110,590 701,357
Accumulated other comprehensive (loss) income (390) 10
Retained earnings (accumulated deficit) 26,922 (7,185)
Total stockholders’ equity 1,137,245 694,294
Total liabilities and stockholders’ equity $ 1,906,387 $ 988,331

Source